MS

Meena Sanghavi Rajendra

Active Director Director DIN 00689670
DIN 00689670 First appointment Aug 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2006
Shareholding value •••• Premium profile

About Meena Sanghavi Rajendra

Data last updated:

Meena Sanghavi Rajendra is a Director at Fuzion Nutraceuticals Private Limited (since 2006). The company operates in Pharma. Fuzion Nutraceuticals Private Limited reported revenue of ₹1.4 Lakh (FY 2024).

DIN 00689670
Primary Designation Director
Industry Pharma
First Appointment 16 Aug 2006
Oldest Company Age 22 yrs
Largest company Fuzion Nutraceuticals Private Limited · ₹1.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Aug 20062003₹1.4 Lakh (FY 2024)Active

Board colleagues of Meena Sanghavi Rajendra

Directorship timeline

Open interactive timeline →
Fuzion Nutraceuticals Private Limited
Premium access

Shareholding and investment profile for Meena Sanghavi Rajendra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meena Sanghavi Rajendra

Meena Sanghavi Rajendra currently holds 1 directorship: Fuzion Nutraceuticals Private Limited (Director, since 16 Aug 2006, revenue ₹1.4 Lakh (FY 2024)).

Meena Sanghavi Rajendra was first appointed on 16 Aug 2006 as Director at Fuzion Nutraceuticals Private Limited.

The current boards of Meena Sanghavi Rajendra's companies include Rajendra Kanaiyalal Sanghavi (Fuzion Nutraceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available